Clinical Trial Update: Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure [Phase 2, Phase 3]

View source ↗

Summary

A completed clinical trial update on glucocorticoid therapy for critically ill COVID-19 patients with severe acute respiratory failure, covering Phase 2 and Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Infections

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: COVID-19 Infections | Phase 2, Phase 3 | Status: COMPLETED